MPM is a cancer which affects the lung pleura, or lining of the lungs. Serous membranes enclose the lungs, and mesothelioma is a variety of cancer that strikes those membranes. Other serous membranes can be affected too including those enclosing the abdomen and heart. The term lung cancer applies precisely to cancers which are born in the lung area.
A contrast between asbestosis and pleural mesothelioma in that the former is not a cancer and the latter is. Asbestosis first appears in the lungs and is results from breathing in asbestos fibers that come to be planted in the pleura. MPM cancer makes up roughly three-fourths of all mesothelioma cases.
Chest discomfort and shortness of breath are common symptoms, but the pain can appear in other areas of the body.The recognition often transpires when the progressing tumors widen the pleural area, producing pain as it fills with fluid. This is known as pleural effusion.
Physical examination
The standard work-up for a patient suspected of mesothelioma consists of noninvasive lab tests, serum tumor markers, X-rays, and computed tomography (CT) scans of the appropriate parts of the body. Markers are substances usually found in the blood or urine that surface as reactions to cancer cells. The appearance, alteration, and change in quantity of these substances are determined to aid in the detection of cancer and assessment of cancer treatments. Over 80% of all cases of MPM will exhibit an enlarged pleural area in chest X-rays.
Pulmonary function tests are employed to gauge the ability of the lungs to inhale, exhale, and transfer oxygen into the blood. Patients with malignant pleural mesothelioma normally exhibit restrictive breathing patterns and reduced oxygen transfer.
Expeditious and accurate diagnosis of MPM is crucial in order to differentiate it from adenocarcinoma, a cancer that is born in tissues of the glands. On occasion , a sample must be taken by fine needle removal from the tumor, especially if there is no apparent effusion.
A Computed Tomography scan adds additional contrast and sensitivity to discover the existence of pleural expansion, tumors, enlargement of the lymph nodes, and evidence of asbestos exposure. If surgery is under evaluation, magnetic resonance imaging can gauge the extent of the tumor within regions such as the diaphragm and ribs. It can , in addition, assist in the planning and execution of localized radiotherapy.
Early Diagnosis
(PET) is an imaging technique to identify chest involvement and movement of the cancer to other parts of the body. PET is nuclear-based and uses small amounts of radioactive matter to assist the diagnosis and treatment, and has the ability to distinguish malignant pleural masses from benign masses.
In the event that noninvasive tests are not conclusive, thoracoscopy is proficient in analyzing the nature and extent of pleural and lung lesions. Thoracoscopy can be used to assist in surgical routines as well as visualization of the affected area. Referred to as VATS, video-assisted thoracoscopic surgery assumes a small probability of distributing a tumor along the openings and chest tube tracts. Invasive tests such as colonoscopy and endoscopy are occasionally required to exclude colon and stomach cancer.